(Alliance News) - Craven House Capital PLC on Friday said its loss narrowed during its most recent financial year, as it also narrows its loss on the fair value of its investments. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
Amigo Holdings PLC - Bournemouth, England-based mid-cost credit provider - Shares are restored to trading in London on Friday following a one-month suspension to allow for discussions with Craven House Capital PLC. Amigo is in the process of winding down its core lending business under a scheme of arrangement overseen by the UK Financial Conduct Authority, after being required to make millions of pounds in customer redress payments. The talks with Craven House were to sell Amigo's other assets and therefore preserve some value for investors. On Thursday, however, Amigo said talks for a reverse takeover by Garimon Ltd and Honeydog Ltd, investees of Craven, were terminated at the request of "various individuals". It called the outcome "disappointing news". Read More
(Alliance News) - Amigo Holdings PLC on Thursday said that talks over its proposed takeover by investee companies of Craven House Capital PLC has been terminated. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday. Read More
Craven House Capital PLC - London-based investment fund with minority shareholding in four Swedish-managed eCommerce and pharmaceutical businesses - Says its investee company Bio Vitos has received approval from Nasdaq Stockholm to acquire shares in Hemcheck Sweden AB. This follows conditional approval being granted in late August. Bio Vitos will now proceed with completing the transaction, Craven House says. Upon completion, Bio Vitos will own 259.7 million Hemcheck shares, or an 88% stake. Craven House has a 25% stake in Bio Vitos. Read More
(Alliance News) - Shares in failed consumer lender Amigo Holdings PLC were suspended from trading in London on Tuesday, as it said it is in discussions with Craven House Capital PLC for a deal that would preserve some, but not much, value for investors. Read More
(Alliance News) - Craven House Capital PLC on Tuesday noted that its investee Bio Vitos Medical Ltd is set to own 88% of medical technology company Hemcheck Sweden AB, after receiving conditional approval from Nasdaq Stockholm. Read More
Craven House Capital PLC - London-based investment fund with minority shareholding in four Swedish-managed eCommerce and pharmaceutical businesses - Notes planned acquisition of investee Bio Vitos by Hemcheck Sweden AB is not approved by Nasdaq. Bio Vitos enter into an agreement that will enable operations to continue, while Hemcheck is in the process of submitting an updated application to Nasdaq. "Bio Vitos anticipates that it will receive its shares in Hemcheck before the end of July 2023 which will be passed directly onto the Bio Vitos shareholders, which include Craven House," Craven says. Craven House has a 24.5% sake in Bio Vitos, a company that sells omega 3 tablets. Hemcheck is a company focused on detecting hemolyzed blood samples. Hemolyzed means red blood cells in a sample burst, usually rendering it unable to yield a test result. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Craven House Capital PLC - London-based investment fund with minority shareholding in four Swedish-managed eCommerce and pharmaceutical businesses - Says Bio Vitos, a company that sells omega 3 tablets and in which Craven House owns a 24.5% stake, enters into an agreement to buy an 88% stake in Hemcheck Sweden AB, a company focused on detecting hemolyzed blood samples. Hemolyzed means red blood cells in a sample burst, usually rendering it unable to yield a test result. Bio Vitos will pay Hemcheck SEK5.2 million, around GBP407,249, in cash for business and assets. Read More
(Alliance News) - Craven House Capital PLC said on Tuesday that its annual loss narrowed while the valuations of its four portfolio valuations remained unchanged. Read More
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
UK shareholder meetings calendar - next 7 days Read More
TRADING UPDATES: ImmuPharma teams with Imperial; Webis results delayed Read More
TRADING UPDATES: Strix launches new products; Sylvania profit down Read More
IN BRIEF: Craven House Loss Narrows After Prior Year Fair Value Hit Read More
IN BRIEF: Craven House Capital Unaware Of Reason For Share Price Hike Read More